Pioneering the future of medicine since 2025
Founded in 2025, NexaGen Pharmaceuticals emerged from a simple belief: that breakthrough science could transform the way we treat disease. What began as a small team of dedicated researchers has grown into one of the world's leading pharmaceutical companies.
Today, NexaGen operates research facilities across three continents, employs over 8,500 scientists, engineers, and healthcare professionals, and serves patients in more than 80 countries. Our treatments have helped over 40 million patients worldwide.
From neurology to oncology, cardiovascular care to mental health, our research spans the spectrum of human medicine. Every day, our teams work to discover the next breakthrough that could change—or save—a patient's life.
Every decision we make is guided by our commitment to improving patient outcomes and quality of life.
We pursue rigorous, evidence-based research to develop treatments that truly work.
We hold ourselves to the highest ethical standards in everything we do.
We embrace bold ideas and cutting-edge technology to solve healthcare's greatest challenges.
Guided by experienced professionals committed to our mission.
Former Chief Scientific Officer with 20 years of pharmaceutical experience.
Leading financial strategy and shareholder relations.
Overseeing clinical development and medical affairs.
Directing our global research and development programs.
1500 Innovation Drive, Metro City, MC 10001
